Foresta Group Holdings Limited (ASX:FGH) Reports Kawerau Project Development Activities

Aditi Sarkar

23 September 2026 05:52 AM AEST

Foresta Group Holdings Limited (ASX:FGH) Reports Kawerau Project Development Activities

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Foresta received NZD$35,000 from Ara Ake for technology review activities.
FEL 1 Concept Study was completed for the Kawerau Project.
US Patent allowance was received for a rosin and terpene production process.
Cash and cash equivalents were approximately $3.43 million at 30 June 2026.

Foresta Group Holdings Limited (ASX:FGH) is developing an integrated biomass Manufacturing platform focused on torrefied wood pellets and pine chemical production. The company’s Kawerau Project in New Zealand is designed around renewable pine resources and proprietary processing methods. During FY2026, Foresta focused on technical studies, project development activities, intellectual property and commercial planning.

Kawerau Project Development

Foresta continued development of the Kawerau Stage 1 Project through engineering studies, infrastructure assessments and technical reviews. The company completed the FEL 1 Concept Study and received a low-carbon process heat feasibility study undertaken with EECA. The study concluded geothermal resources are technically and commercially suitable for the project’s process heat requirements.

Technology and Intellectual Property Activities

Foresta received NZD$35,000 in grant funding from Ara Ake to support an independent review of its Torrefaction after Pelletisation technology. The company also received allowance from the United States Patent and Trademark Office for its rosin and terpene production process. The patent application relates to Foresta’s pine chemical processing technology.

Financial Position and FY2026 Outlook

Foresta reported a FY2026 net loss of approximately $6.82 million. The result included project-related expenses, finance costs and Impairment of the Kawerau right-of-use asset. The company received a final insurance settlement payment of $2.4 million, bringing total insurance proceeds related to the Apple Tree Creek incident to $4.6 million. At 30 June 2026, cash and cash equivalents were approximately $3.43 million. FY2026-27 priorities include project development, funding discussions, design work and stakeholder engagement.

Key Insights

Foresta Group Holdings continues working on the Kawerau Project through engineering studies, technology assessment and commercial planning for a proposed biomass manufacturing facility.

FAQs

Q: What does Foresta Group Holdings do?

A: Foresta develops biomass processing technology focused on torrefied wood pellets and pine chemicals.

Q: What is the Kawerau Project?

A: It is Foresta’s proposed integrated biomass manufacturing facility in New Zealand.

Q: What grant did Foresta receive from Ara Ake?

A: Foresta received NZD$35,000 for an independent technology review.

Q: What patent update was announced?

A: Foresta received US patent allowance for its rosin and terpene production process.

Q: What was the cash balance at 30 June 2026?

A: Cash and cash equivalents were approximately $3.43 million.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.